Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
achromatopsia
beta-thalassemia
bill cassidy
1
×
bluebird bio
boston blog main
boston top stories
clinical trials
deals
dna
fda
gene therapy
harvard pilgrim health care
1
×
hemophilia
johnson & johnson
life sciences
luxturna
1
×
mark warner
1
×
mathai mammen
medicaid
meiragtx
national blog main
national top stories
new york
new york blog main
new york top stories
novartis
patient affordability value and efficiency act
spark therapeutics
spinal muscular atrophy
university of pennsylvania
value based agreements
x-linked retinitis pigmentosa
zolgensma
What
age
bigger
biggest
come
deal
emerging
gave
gene
j
johnson
meiragtx
morning
1
×
past
signal
signals
therapy
years
Language
Current search:
luxturna
×
morning
×
" mark warner "
×
" harvard pilgrim health care "
×
" bill cassidy "
×
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy